EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual antibacterial action of ethyl ferulate as antibiofilm molecule and antibiotic synergist against Escherichia coli

Zhijin Zhang, Yubin Bai, Jing Xu, Rongbin Hu, Zixuan Shang, Xiaojuan Wei, Weiwei Wang, Bing Li, Zhen Zhu, Jiyu Zhang

Frontiers in Cellular and Infection Microbiology · 07.04.2026 · 16

DOI: 10.3389/fcimb.2026.1789180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.04.2026. Verfasst von Zhijin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of the Ministry of Agriculture, …. Hauptthemen laut MEDLINE: Escherichia coli, Biofilms, Anti-Bacterial Agents, Drug Synergism. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The biofilm formed by Escherichia coli enhances its pathogenicity and antibiotic resistance, posing a serious threat to human and animal health.

Methods

This study evaluated the anti-biofilm and synergistic antibacterial effects of ethyl ferulate (EF) on E. coli using crystal violet (CV) staining and Alamar Blue (AB) assay. The expression levels of biofilm-related genes were analyzed by qRT-PCR.

Results

The results demonstrated that EF effectively inhibited the formation of E. coli biofilm and the production of exopolysaccharides (EPS), while enhancing bacterial motility without affecting bacterial growth and metabolic activity. qRT-PCR analysis revealed that EF treatment significantly downregulated the expression of curli-related gene csgD and c-di-GMP-related genes ( pdeR and dgcM ), while upregulating the expression of flagella-related genes ( fliC , fliM , and motB ). Notably, EF exhibited significant antimicrobial synergistic effects when combined with commercially available antibiotics (fosfomycin sodium, cefquinome, gentamicin, tetracycline, and azithromycin), markedly enhancing their antibacterial efficacy.

Discussion

These findings demonstrate that EF possesses potent anti-biofilm activity and holds promise as an antibacterial synergist, offering a promising strategy for the treatment of E. coli infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliBiofilmsAnti-Bacterial AgentsDrug SynergismMicrobial Sensitivity TestsGene Expression Regulation, BacterialPolysaccharides, BacterialEscherichia coli Proteins

Stichwörter der Autor:innen

Escherichia coliantibacterial synergistantibiofilmextracellular polymeric substancemotility

Substanzen

Anti-Bacterial AgentsPolysaccharides, BacterialEscherichia coli Proteins

Autor:innen und Institutionen

  • Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of the Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese…
  • College of Life Science and Food Engineering, Hebei University of Engineering, Handan, Hebei, China.

Zitieren

APA

Zhang, Z., Bai, Y., Xu, J., Hu, R., Shang, Z., Wei, X., Wang, W., Li, B., Zhu, Z., & Zhang, J. (2026). Dual antibacterial action of ethyl ferulate as antibiofilm molecule and antibiotic synergist against Escherichia coli. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1789180

Vancouver

Zhang Z, Bai Y, Xu J, Hu R, Shang Z, Wei X, et al. Dual antibacterial action of ethyl ferulate as antibiofilm molecule and antibiotic synergist against Escherichia coli. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1789180

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhijin and Bai, Yubin and Xu, Jing and Hu, Rongbin and Shang, Zixuan and Wei, Xiaojuan and Wang, Weiwei and Li, Bing and Zhu, Zhen and Zhang, Jiyu},
  title = {Dual antibacterial action of ethyl ferulate as antibiofilm molecule and antibiotic synergist against Escherichia coli},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1789180}
}
Kostenlos starten →